SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-20-007021
Filing Date
2020-02-27
Accepted
2020-02-27 07:17:28
Documents
84
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sage-10k_20191231.htm   iXBRL 10-K 3981173
2 EX-4.2 sage-ex42_260.htm EX-4.2 36353
3 EX-21.1 sage-ex211_10.htm EX-21.1 10334
4 EX-23.1 sage-ex231_6.htm EX-23.1 2229
5 EX-31.1 sage-ex311_9.htm EX-31.1 9312
6 EX-31.2 sage-ex312_8.htm EX-31.2 9248
7 EX-32.1 sage-ex321_7.htm EX-32.1 7631
8 GRAPHIC gch5zcj2c1iw000003.jpg GRAPHIC 40405
9 GRAPHIC gch5zcj2c1iw000001.jpg GRAPHIC 40405
10 GRAPHIC gch5zcj2c1iw000002.jpg GRAPHIC 28946
  Complete submission text file 0001564590-20-007021.txt   12994958

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA sage-20191231.xsd EX-101.SCH 69132
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sage-20191231_cal.xml EX-101.CAL 65910
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sage-20191231_def.xml EX-101.DEF 239674
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20191231_lab.xml EX-101.LAB 529656
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20191231_pre.xml EX-101.PRE 428163
31 EXTRACTED XBRL INSTANCE DOCUMENT sage-10k_20191231_htm.xml XML 2533285
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36544 | Film No.: 20658462
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences